Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Earnings for Insulet Corporation (PODD)
Earnings in 2023 (TTM): $214.6 M
According to Insulet Corporation's latest financial reports the company's current earnings (TTM) are $214.6 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Insulet Corporation
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $214.6 M | $206.3 M |
| 2022 | $9.8 M | $4.6 M |
| 2021 | $20.5 M | $16.8 M |
| 2020 | $9.7 M | $6.8 M |
| 2019 | $14.5 M | $11.6 M |
| 2018 | $5.23 M | $3.29 M |
| 2017 | $-26,574,000 | $-26,831,000 |
| 2016 | $-26,818,000 | $-28,879,000 |
| 2015 | $-61,390,000 | $-73,520,000 |
| 2014 | $-51,358,000 | $-51,500,000 |
| 2013 | $-44,874,000 | $-44,974,000 |
| 2012 | $-51,655,000 | $-51,867,000 |
| 2011 | $-57,043,000 | $-57,170,000 |
| 2010 | $-61,159,000 | $-61,159,000 |
| 2009 | $-79,541,000 | $-79,541,000 |
| 2008 | $-92,791,000 | $-92,791,000 |
| 2007 | $-53,539,000 | $-53,539,000 |
| 2006 | $-35,490,000 | $-35,950,000 |
| 2005 | $ | $-21,636,000 |
| 2004 | $ | $-13,821,000 |
| 2003 | $ | $-11,941,000 |
| 2002 | $ | $-12,580,000 |